In:
Recent Advances in Anti-Infective Drug Discovery, Bentham Science Publishers Ltd., Vol. 18, No. 1 ( 2023-03-23), p. 54-68
Abstract:
COVID- 19 vaccines have been released, giving a major hope of getting
rid of the dark pandemic crisis. The availability of vaccines does not necessarily mean that the mass vaccination program is a success. We aimed to investigate COVID-19 vaccination
knowledge level, acceptance rate, and perception state among Egyptians. Methods: An analytical cross-sectional online survey was carried out utilizing a selfadministered
adult questionnaire that assesses vaccination acceptance with related sociodemographic factors and perceptions based on health belief model perspectives. Predictors of
vaccination acceptance were based on logistic regression analysis. Results: We analyzed data for 957 participants, aged 18–78 years, 55.7% were females, and
66.9% were healthcare workers (HCWs). About one-fourth had a history of confirmed COVID-19 infection and 56.5% would accept to have one of the COVID-19 vaccines, where
“Pfizer” was the preferable one (37.8%), while “AstraZeneca” was the most rejected vaccine (26.8%). The 1st vaccine dose was received by 273 (28.5%) of which 260 were intended to
receive the 2nd dose. Vaccine efficacy, side effects, protection time, and administration route were essentially among the factors that may influence their decision to accept COVID-19
vaccines. About 83.1% had good knowledge about vaccination which was significantly higher with increased age, among graduates/professionals, governmental workers, HCWs in addition
to those able to save/invest money, had a history of confirmed COVID-19 infection and intending
to have COVID-19 vaccine. Perceptions that vaccination decreases the chance of getting COVID-19 or its complications (OR = 9.28; CI: 5.03-17.12), vaccination makes less worry
about catching COVID-19 (OR = 6.76; CI: 3.88-11.76), and being afraid of getting COVID-19 (OR = 2.04; CI: 1.26–3.31) were strong significant predictors for vaccine acceptance. Conclusions: Vaccine campaigns should emphasize vaccine benefits and highlight the severity
of infection while addressing barriers to vaccination in order to improve vaccine coverage among populations.
Type of Medium:
Online Resource
ISSN:
2772-4344
DOI:
10.2174/2772434417666220907151635
Language:
English
Publisher:
Bentham Science Publishers Ltd.
Publication Date:
2023
Permalink